Roberta Baldoncini

690 total citations
17 papers, 499 citations indexed

About

Roberta Baldoncini is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Roberta Baldoncini has authored 17 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 8 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Roberta Baldoncini's work include Nitric Oxide and Endothelin Effects (7 papers), Cardiovascular Function and Risk Factors (4 papers) and Heart Failure Treatment and Management (3 papers). Roberta Baldoncini is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Cardiovascular Function and Risk Factors (4 papers) and Heart Failure Treatment and Management (3 papers). Roberta Baldoncini collaborates with scholars based in Italy. Roberta Baldoncini's co-authors include Claudio Ferri, Cesare Bellini, Giovambattista Desideri, Giancarlo De Mattia, Anna Santucci, Annalisa Santucci, C. De Angelis, O. Laurenti, Giuliana Properzi and Marco Valenti and has published in prestigious journals such as Circulation, Diabetes Care and Diabetes.

In The Last Decade

Roberta Baldoncini

17 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Baldoncini Italy 9 286 237 119 92 65 17 499
Alfonso Piccoli Italy 11 319 1.1× 197 0.8× 135 1.1× 36 0.4× 96 1.5× 17 527
Rosine Nzietchueng France 12 186 0.7× 341 1.4× 62 0.5× 55 0.6× 98 1.5× 14 618
Debbie L. Ceiler Netherlands 6 287 1.0× 193 0.8× 163 1.4× 142 1.5× 131 2.0× 8 593
Mara Fallarino Italy 14 153 0.5× 154 0.6× 141 1.2× 170 1.8× 120 1.8× 20 562
Margarita Garcı́a-Durán Spain 10 186 0.7× 274 1.2× 85 0.7× 28 0.3× 115 1.8× 12 528
Concha F. García‐Prieto Spain 17 321 1.1× 248 1.0× 96 0.8× 115 1.3× 145 2.2× 22 713
J Higaki Japan 13 501 1.8× 129 0.5× 309 2.6× 74 0.8× 163 2.5× 19 789
Glória F.A. Mota Brazil 12 167 0.6× 90 0.4× 104 0.9× 45 0.5× 109 1.7× 12 466
Kojiro Ichikawa Japan 11 165 0.6× 51 0.2× 95 0.8× 37 0.4× 62 1.0× 14 390
Ioulia Vitta Greece 9 152 0.5× 116 0.5× 84 0.7× 157 1.7× 76 1.2× 10 446

Countries citing papers authored by Roberta Baldoncini

Since Specialization
Citations

This map shows the geographic impact of Roberta Baldoncini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Baldoncini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Baldoncini more than expected).

Fields of papers citing papers by Roberta Baldoncini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Baldoncini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Baldoncini. The network helps show where Roberta Baldoncini may publish in the future.

Co-authorship network of co-authors of Roberta Baldoncini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Baldoncini. A scholar is included among the top collaborators of Roberta Baldoncini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Baldoncini. Roberta Baldoncini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferri, Claudio, Cesare Bellini, Giovambattista Desideri, et al.. (2009). Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Experimental and Clinical Endocrinology & Diabetes. 105(S 02). 38–40. 33 indexed citations
2.
Baldoncini, Roberta, Giovambattista Desideri, Cesare Bellini, et al.. (1999). High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients. Kidney International. 56(4). 1499–1504. 30 indexed citations
3.
Ferri, Claudio, Giovambattista Desideri, Roberta Baldoncini, et al.. (1999). Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels. Clinical Science. 96(3). 261–270. 28 indexed citations
4.
Cassone‐Faldetta, M., Chiara Bellini, Maria Cristina Bravi, et al.. (1998). Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. American Journal of Hypertension. 11(8). 983–988. 53 indexed citations
5.
Ferri, Claudio, Giovambattista Desideri, Roberta Baldoncini, et al.. (1998). Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.. Diabetes. 47(4). 660–667. 111 indexed citations
6.
Ferri, Claudio, Cesare Bellini, Giovambattista Desideri, et al.. (1997). Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalities. Diabetologia. 40(1). 100–102. 24 indexed citations
7.
Ferri, Claudio, Paolo De Marzio, Giovambattista Desideri, et al.. (1997). Plasma endothelin‐1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularization. European Journal of Clinical Investigation. 27(6). 526–532. 3 indexed citations
8.
Baldoncini, Roberta, et al.. (1997). Elevated Albumin Excretion in Nonmodulating Essential Hypertensive Patients. Nephron. 76(3). 264–269. 4 indexed citations
9.
Baldoncini, Roberta, Claudio Ferri, Cesare Bellini, et al.. (1996). Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.. PubMed. 19(1). 13–9. 1 indexed citations
10.
Ferri, Claudio, et al.. (1995). Hormonal and Renal Responses to Atrial Natriuretic Peptide Infusion in Low-Renin Hypertension. American Journal of Nephrology. 15(3). 222–229. 6 indexed citations
11.
Ferri, Claudio, Cesare Bellini, Giovambattista Desideri, et al.. (1995). Plasma Endothelin-1 Levels in Obese Hypertensive and Normotensive Men. Diabetes. 44(4). 431–436. 106 indexed citations
12.
Ferri, Claudio, Roberta Baldoncini, O. Laurenti, et al.. (1995). Circulating Endothelin-1 Levels Increase During Euglycemic, Hyperinsulinemic Clamp in Lean NIDDM Men. Diabetes Care. 18(2). 226–233. 76 indexed citations
13.
Baldoncini, Roberta, Claudio Ferri, Luca De Siati, et al.. (1994). Effects of Atrial Natriuretic Factor Infusion on Plasma Prorenin Levels in Hypertensive Males. Clinical and Experimental Hypertension. 16(3). 283–302. 1 indexed citations
14.
Ferri, Claudio, et al.. (1994). Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients.. Circulation. 90(6). 2859–2869. 15 indexed citations
15.
Ferri, Claudio, G. De Mattia, Cesare Bellini, et al.. (1993). Octreotide, a Somatostatin Analog, Reduces Insulin Secretion and Increases Renal Na+ Excretion in Lean Essential Hypertensive Patients. American Journal of Hypertension. 6(4). 276–281. 5 indexed citations
16.
Siati, Luca De, Roberta Baldoncini, Claudio De Angelis, et al.. (1993). Renal Sodium Excretory Function during Acute Oxygen Administration. Respiration. 60(6). 338–342. 1 indexed citations
17.
Ferri, Claudio, Roberta Baldoncini, Cesare Bellini, et al.. (1993). [Sodium-modulating hormones and the pressor response to sodium chloride in essential arterial hypertension].. PubMed. 8(2). 89–94. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026